These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Acute myocardial infarction in diabetic patients in the thrombolytic era. Lynch M; Gammage MD; Lamb P; Nattrass M; Pentecost BL Diabet Med; 1994 Mar; 11(2):162-5. PubMed ID: 8200200 [TBL] [Abstract][Full Text] [Related]
4. [The role of diabetes mellitus as a risk factor of acute myocardial infarction]. Peng XR; Zhao YF; Zou DJ; Gu P Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):322-8. PubMed ID: 21672377 [TBL] [Abstract][Full Text] [Related]
5. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Sewdarsen M; Vythilingum S; Jialal I; Becker PJ Q J Med; 1989 May; 71(265):461-6. PubMed ID: 2602543 [TBL] [Abstract][Full Text] [Related]
6. Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era. Hansen HH; Joensen AM; Riahi S; Malczynski J; Mølenberg D; Ravkilde J Scand Cardiovasc J; 2007 Jan; 41(1):19-24. PubMed ID: 17365973 [TBL] [Abstract][Full Text] [Related]
7. Myocardial infarction in patients with diabetes mellitus. Malmberg K; Rydén L Eur Heart J; 1988 Mar; 9(3):259-64. PubMed ID: 3383866 [TBL] [Abstract][Full Text] [Related]
8. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries. Svensson AM; Dellborg M; Abrahamsson P; Karlsson T; Herlitz J; Duval SJ; Berger AK; Luepker RV Int J Cardiol; 2007 Jul; 119(3):319-25. PubMed ID: 17067706 [TBL] [Abstract][Full Text] [Related]
9. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. Woodfield SL; Lundergan CF; Reiner JS; Greenhouse SW; Thompson MA; Rohrbeck SC; Deychak Y; Simoons ML; Califf RM; Topol EJ; Ross AM J Am Coll Cardiol; 1996 Dec; 28(7):1661-9. PubMed ID: 8962549 [TBL] [Abstract][Full Text] [Related]
10. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639 [TBL] [Abstract][Full Text] [Related]
11. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Dziewierz A; Giszterowicz D; Siudak Z; Rakowski T; Dubiel JS; Dudek D Clin Res Cardiol; 2010 Nov; 99(11):715-21. PubMed ID: 20458486 [TBL] [Abstract][Full Text] [Related]
12. Factors that influence outcome in diabetic subjects with myocardial infarction. Fava S; Azzopardi J; Muscat HA; Fenech FF Diabetes Care; 1993 Dec; 16(12):1615-8. PubMed ID: 8299458 [TBL] [Abstract][Full Text] [Related]
13. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with ST-elevation acute myocardial infarction. Li DB; Hua Q; Guo J; Li HW; Chen H; Zhao SM Intern Med; 2011; 50(21):2471-5. PubMed ID: 22041344 [TBL] [Abstract][Full Text] [Related]
14. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Barbash GI; White HD; Modan M; Van de Werf F J Am Coll Cardiol; 1993 Sep; 22(3):707-13. PubMed ID: 8354802 [TBL] [Abstract][Full Text] [Related]
15. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Malmberg K; Norhammar A; Wedel H; Rydén L Circulation; 1999 May; 99(20):2626-32. PubMed ID: 10338454 [TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar. Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492 [TBL] [Abstract][Full Text] [Related]
17. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A; Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645 [TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Granger CB; Califf RM; Young S; Candela R; Samaha J; Worley S; Kereiakes DJ; Topol EJ J Am Coll Cardiol; 1993 Mar; 21(4):920-5. PubMed ID: 8450161 [TBL] [Abstract][Full Text] [Related]